| Location: | Federal |
|---|---|
| Posted: | Jan 9, 2026 |
| Due: | Feb 20, 2026 |
| Agency: | HEALTH AND HUMAN SERVICES, DEPARTMENT OF |
| Type of Government: | Federal |
| Category: |
|
| Publication URL: | To access bid details, please log in. |
This Special Notice is not a formal Invitation for Bid (IFB), Request for Proposal (RFP), Request for Quotation (RFQ) nor any type of Solicitation for offers. In accordance with FAR 15.201(d), this Special Notice is intended FOR INFORMATIONAL PURPOSES ONLY in order to publicize the requirements of the Frederick National Laboratory for Cancer Research (FNLCR).
The FNLCR is a Government-Owned Contractor-Operated Federally Funded Research and Development Center (FFRDC) located at Fort Detrick, Maryland. The FNLCR partners with university, Government, and corporate scientists to speed the translation of laboratory research into new diagnostic tests and treatments for cancer and AIDS. FNLCR is a multi-program laboratory currently operated by Leidos Biomedical Research, Inc. (Leidos Biomed) for the National Cancer Institute (NCI) under Prime Contract No. 75N91019D00024 & HHSN261201500003I, which provides Operations and Technical Support (OTS) for the FNLCR.
The Government assumes no liability for reimbursement for any effort or associated costs to respond, nor for any information provided as a result of this Special Notice as no information is being requested. Please be advised that any submissions provided, despite that no information is requested, become Government property and will not be returned, nor will there be any ensuing discussions or debriefings.
Responses submitted to this Special Notice are not offers and cannot be accepted by the U.S. Government to form a binding contract. It is the responsibility of the interested parties to monitor this site and any sites referenced herein for additional information pertaining to business opportunities with the FNLCR, if any.
Description of Work: This request for information is to determine the level of interest for the staffing of an Occupational Health Services Office on the National Cancer Institute (NCI) Frederick Campus, located in Frederick, MD.
The NCI at Frederick Occupational Health Services (OHS) Office strives to protect, maintain, and promote the health of approximately 2,700 employees in laboratories and animal facilities, to include both Government and Leidos Biomed personnel. These facilities include BSL-1 and –2 and a small number of BSL-2 labs with BSL-3 practices. Our professional staff is devoted to the prevention and management of occupational and environmental injury, illness, exposure, and disabilities.
Leidos Biomedical Research, Inc. Point of Contact for a copy of Solicitation/RFP No: S26-114:
Chad Hildebrand at chad.hildebrand@nih.gov and Cody Wenner at cody.wenner@nih.gov
For information concerning other opportunities with the FNLCR, please refer to:
https://frederick.cancer.gov/workwithus/solicitations

With GovernmentContracts, you can: